Labshake search
Citations for Peprotech :
1 - 50 of 2218 citations for IL 17RA Human HEK 293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... FBs were then stimulated with 10ng/ml TGFβ1 (HEK-293-derived, Peprotech, Rocky Hill, NJ, USA), and with or without DPP4-inhibitor Sitagliptin (10μM ...
-
bioRxiv - Microbiology 2020Quote: ... recombinant human IL-10 (Peprotech) was added to the culture medium ...
-
bioRxiv - Immunology 2019Quote: ... Recombinant human IL-2 (Peprotech) was provided at 100 U/mL ...
-
bioRxiv - Immunology 2022Quote: ... human IL-12p70 (HEK293) (Peprotech) and 50ng/ml recombinant human IL-18 (MBL International ...
-
bioRxiv - Immunology 2023Quote: ... Recombinant human IL-4 (Peprotech 200-04 ...
-
bioRxiv - Immunology 2023Quote: Recombinant human IL-2 (Peprotech 200-02 ...
-
bioRxiv - Immunology 2023Quote: ... Recombinant human IL-21 (Peprotech 200-21 ...
-
bioRxiv - Cell Biology 2022Quote: ... FBs were then stimulated with 10□ng/ml TGFβ1 (HEK-293-derived, Peprotech, Rocky Hill, NJ, USA), and with medium or PBMCsec for 24□h ...
-
bioRxiv - Immunology 2022Quote: ... 1% Penicilin/Streptomycin) supplemented with 5 ng/ml human IL-7 and human IL-15 (Peprotech) each ...
-
bioRxiv - Bioengineering 2023Quote: ... 20 ng/ml human IL-4 and 10 ng/ml human IL-10 (Peprotech, NJ, USA) overnight ...
-
bioRxiv - Microbiology 2020Quote: ... human IL-4 (40ng/ml, PeproTech) and GM-CSF (50ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... human IL-2 (Peprotech, #200-02) used at 100 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... human IL-21 (Peprotech, #210-21) used at 20 ng/ml ...
-
bioRxiv - Cell Biology 2024Quote: ... or human recombinant IL-13 (PeproTech) were included in medium additions on days 3 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Recombinant human IL-1β and IL-3 was purchased from PeproTech. TLR-5 was purchased from Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... IL-7 and IL-33 (human and mouse) were from PeproTech. TLR4 agonist ...
-
bioRxiv - Immunology 2020Quote: Human PBMCs were stimulated with recombinant human IL-12 (Peprotech) and IL-18 (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... or TFH mimicking signals (including 0.02 μg/mL recombinant human IL-4, Peprotech; 0.05 μg/ml recombinant human IL-21, Peprotech, and 5 μg/mL anti-human CD40 ...
-
bioRxiv - Bioengineering 2020Quote: ... Recombinant human IL-2 (200-02, Peprotech), recombinant human IL-15 (570308 ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human IL-2 (Peprotech, 1ng/ml) was added to the wells at timepoint 0h ...
-
bioRxiv - Immunology 2022Quote: ... human IL-15 (20 ng/mL, Peprotech), human IL-12 (10 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... and 5ng/mL human IL-4 (Peprotech) for 3 more days ...
-
bioRxiv - Microbiology 2020Quote: ... 2μg/mL anti-human IL-12 (PeproTech), 1μg/mL anti-human IL-4 (PeproTech) ...
-
bioRxiv - Microbiology 2020Quote: ... 1μg/mL anti-human IL-4 (PeproTech), and 10ng/mL of TGF-β1 ...
-
bioRxiv - Immunology 2022Quote: ... human IL-12 (10 ng/mL, Peprotech), and/or human IL-18 (100 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... human recombinant IL-7 (200-07, Peprotech), human recombinant TNF (H8916 ...
-
bioRxiv - Immunology 2021Quote: ... human IL-3 (10 ng/mL; Peprotech) and 3% supernatant of CHO transfectants secreting murine SCF (a gift from Dr ...
-
bioRxiv - Immunology 2020Quote: ... 6000IU/ml Recombinant Human IL-2 (Peprotech), 5ng/ml Recombinant Human IL-7 (Peprotech) ...
-
bioRxiv - Immunology 2020Quote: ... 5ng/ml Recombinant Human IL-7 (Peprotech), 5ng/ml Recombinant Human IL-15 (Peprotech ...
-
bioRxiv - Immunology 2020Quote: ... 5ng/ml Recombinant Human IL-15 (Peprotech) and 10mM N-Acetyl-L-cysteine (Sigma) ...
-
bioRxiv - Immunology 2020Quote: ... human IL-2 (10 IU/mL, PeproTech), Paclitaxel (200 nM ...
-
bioRxiv - Bioengineering 2022Quote: ... Recombinant human IL-2 (200-02, Peprotech), recombinant human IL-15 (570308 ...
-
bioRxiv - Immunology 2022Quote: ... human IL-2 (Peprotech, Catalog #200-02). When indicated ...
-
bioRxiv - Immunology 2022Quote: ... human IL-21 (Peprotech, Catalog #210-21) used at 20 ng/ml ...
-
bioRxiv - Immunology 2023Quote: ... 100 ng/mL human IL-34 (Peprotech), and 10 ng/mL human GM-CSF (Peprotech) ...
-
bioRxiv - Immunology 2023Quote: ... 100 ng/mL human IL-21 (Peprotech) and 20 μg/mL anti-IgM antibody (polyclonal F(ab’)2 fragment goat anti-human ...
-
bioRxiv - Cell Biology 2024Quote: ... 10 ng/ml human IL-27 (Peprotech), 10 ng/ml human IL-25 (Peprotech) ...
-
bioRxiv - Cell Biology 2024Quote: ... 10 ng/ml human IL-25 (Peprotech), 10 ng/ml human SCF (Peprotech) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/ml human IL-4 (Peprotech) and 5 ng/ml human IL-13 (Peprotech ...
-
bioRxiv - Cell Biology 2024Quote: ... human recombinant interleukin-6 (IL-6; PeproTech) or human recombinant IL-13 (PeproTech ...
-
bioRxiv - Immunology 2024Quote: ... Recombinant human IL-2 (PeproTech, 200-02) was added to T cells and NK cells cultures at 50 IU mL-1 or 200 IU mL-1 ...
-
bioRxiv - Immunology 2021Quote: ... cells were treated with human IL-17 and human TNFα (Peprotech) for 8 h.
-
bioRxiv - Immunology 2021Quote: ... and 10 U/ml human IL-2 (Peprotech). After 48 hours ...
-
bioRxiv - Molecular Biology 2021Quote: ... and human IL-1β (Peprotech, AF-200-01B) were used for the experiments in Figure S2.
-
bioRxiv - Neuroscience 2020Quote: ... 20ng/ml human IL-3 (Peprotech; 200-03) and 10ng/ml Human IL-6 (Peprotech ...
-
bioRxiv - Immunology 2021Quote: ... human IL-3 (10 ng mL-1; Peprotech) and 3% supernatant of CHO transfectants secreting murine SCF (a gift from Dr ...
-
bioRxiv - Immunology 2021Quote: ... and 10 ng/mL human IL-4 (PeproTech). In the case of tolDCs ...
-
bioRxiv - Immunology 2021Quote: ... 50 ng/mL recombinant human IL-4 (PeproTech), and 50 ng/mL recombinant human GM-CSF (PeproTech ...
-
bioRxiv - Immunology 2022Quote: ... recombinant human IL-1β from PeproTech (#200-01B).
-
bioRxiv - Immunology 2022Quote: ... and 10 ng/mL human IL-4 (PeproTech). In the case of the cells treated with vitamin C ...